Aytu BioPharma Inc (NASDAQ: AYTU) on Friday, plunged -6.45% from the previous trading day, before settling in for the closing price of $1.86. Within the past 52 weeks, AYTU’s price has moved between $0.95 and $2.85.
During the last 5-year period, the sales growth of Healthcare Sector giant was 48.61%. The company achieved an average annual earnings per share of 47.79%. With a float of $8.67 million, this company’s outstanding shares have now reached $8.98 million.
Aytu BioPharma Inc (AYTU) Insider Activity
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Aytu BioPharma Inc is 12.52%, while institutional ownership is 34.47%. The most recent insider transaction that took place on Jun 09 ’25, was worth 24,999. In this transaction Chief Business Officer of this company bought 16,666 shares at a rate of $1.50, taking the stock ownership to the 29,462 shares. Before that another transaction happened on Jun 09 ’25, when Company’s Chief Executive Officer bought 66,666 for $1.50, making the entire transaction worth $99,999. This insider now owns 153,257 shares in total.
Aytu BioPharma Inc (AYTU) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.15 earnings per share (EPS) for the period topping the consensus outlook (set at -0.34) by 0.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around 47.79% per share during the next fiscal year.
Aytu BioPharma Inc (NASDAQ: AYTU) Trading Performance Indicators
Aytu BioPharma Inc (AYTU) is currently performing well based on its current performance indicators. A quick ratio of 1.07 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.81, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of Aytu BioPharma Inc (AYTU)
Looking closely at Aytu BioPharma Inc (NASDAQ: AYTU), its last 5-days average volume was 0.8 million, which is a jump from its year-to-date volume of 0.55 million. As of the previous 9 days, the stock’s Stochastic %D was 5.54%.
During the past 100 days, Aytu BioPharma Inc’s (AYTU) raw stochastic average was set at 33.33%, which indicates a significant increase from 4.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1570 in the past 14 days, which was higher than the 0.1523 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.3369, while its 200-day Moving Average is $1.7599. However, in the short run, Aytu BioPharma Inc’s stock first resistance to watch stands at $1.8490. Second resistance stands at $1.9581. The third major resistance level sits at $2.0325. If the price goes on to break the first support level at $1.6655, it is likely to go to the next support level at $1.5911. Should the price break the second support level, the third support level stands at $1.4820.
Aytu BioPharma Inc (NASDAQ: AYTU) Key Stats
Market capitalization of the company is 17.25 million based on 9,912K outstanding shares. Right now, sales total 81,000 K and income totals -15,840 K. The company made 18,450 K in profit during its latest quarter, and 3,990 K in sales during its previous quarter.
